Geron | GERN - Sales Revenues

Stock Price
1.58
Daily Change
-0.05 -2.78%
Monthly
-17.97%
Yearly
-7.35%
Q1 Forecast
1.53

Geron reported $48.02M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Amgen USD 9.9B 340M Dec/2025
Bio Techne USD 295.9M 9.34M Dec/2025
Cytokinetics USD 17.76M 15.83M Dec/2025
Esperion Therapeutics USD 168.45M 81.14M Dec/2025
Exelixis USD 598.66M 860K Dec/2025
Genmab DKK 5.86B 580M Jun/2025
Geron USD 48.02M 820K Dec/2025
Gilead Sciences USD 7.93B 130M Dec/2025
Incyte USD 1.51B 140M Dec/2025
MacroGenics USD 72.84M 50.6M Sep/2025
Novartis USD 13.91B 144M Sep/2025
Novavax USD 147.14M 76.69M Dec/2025